Feltl & Co Downgrades Dipexium Pharmaceuticals (DPRX) to Hold

October 25, 2016 11:52 AM EDT
Get Alerts DPRX Hot Sheet
Price: $1.45 +3.57%

Rating Summary:
    1 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade DPRX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Feltl & Co downgraded Dipexium Pharmaceuticals (NASDAQ: DPRX) from Buy to Hold.

For an analyst ratings summary and ratings history on Dipexium Pharmaceuticals click here. For more ratings news on Dipexium Pharmaceuticals click here.

Shares of Dipexium Pharmaceuticals closed at $12.75 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Add Your Comment